Skip to content

Irinotecan USP Related Compound D

Irinotecan USP Related Compound D

Product Description
CAT No.
ALN-I010005
CAS No.
NA
Mol. F.
C33H38N4O6 : HCl : 3(H2O)
Mol. Wt.
586.7 : 36.5 : 3(18.0)
Stock
Please Inquire
Chemical Name : (R)-9-[(1,4′-Bipiperidine)-1′-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline hydrochloride, trihydrate (as per USP)
Smiles : O[C@](C(OC1)=O)(CC)C2=C1C(N3C(C4=NC5=CC=C(OC(N6CCC(N7CCCCC7)CC6)=O)C=C5C(CC)=C4C3)=C2)=O.Cl
Inchi : InChI=1S/C22H20N2O5/c1-3-12-13-7-11(25)5-6-17(13)23-19-14(12)9-24-18(19)8-16-15(20(24)26)10-29-21(27)22(16,28)4-2/h5-8,25,28H,3-4,9-10H2,1-2H3/t22-/m0/s1

RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)

By Vijaya Jyothi, M.; Bhargav, E.; Keerthana, B.; Varalakshmi, Devi K.nFrom International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2018), 9(1), 63-67

Method development, validation and forced degradation studies of Irinotecan in bulk and pharmaceutical dosage form

By Swathi, Koduru; Farooqui, Tahmeena; Muntaha, Sidra Tul; Ayesha, Syeda Amtul; Shama, Syeda; Siddiqui, Sarah Imam – From World Journal of Pharmacy and Pharmaceutical Sciences (2018), 7(8), 996-1009

Request For Quotation